Literature DB >> 19438456

Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss.

L Yip1, S Zaloumis, D Irwin, G Severi, J Hopper, G Giles, S Harrap, R Sinclair, J Ellis.   

Abstract

BACKGROUND: Female pattern hair loss (FPHL) is a common trait in which androgens and oestrogens may have a pathogenic role. The aromatase enzyme converts androgens to oestrogens in scalp hair follicles and is differentially expressed in balding and nonbalding scalps of women. Sequence variation in the gene encoding aromatase, CYP19A1, might influence the risk of developing FPHL.
OBJECTIVES: To examine the role of CYP19A1 genetic variation in the heritability of FPHL.
METHODS: We investigated associations between FPHL and 61 tag single nucleotide polymorphisms (SNPs) representing variation in and around CYP19A1 in 484 caucasian women with grades 3-5 FPHL on the Sinclair scale, and 471 caucasian women with no evidence of hair loss.
RESULTS: For the tag SNP rs4646 (overall genotype frequencies: CC, 53.6%; AC, 39.3%; AA, 7.1%), the genotype CC was more frequent in women with FPHL (58.1%) than controls (48.9%) (P = 0.006). Although this result did not achieve experiment-wide significance (P < 0.001 by permutation testing), subanalyses according to sources of recruitment and ages at presentation revealed consistent patterns of association. In particular, young cases (< 40 years) had the highest frequency of the CC genotype (68.2%) among all subgroups.
CONCLUSIONS: These findings suggest that the common rs4646 C allele, which has been associated previously with higher circulating oestrogen levels, might be associated with predisposition to FPHL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19438456     DOI: 10.1111/j.1365-2133.2009.09186.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  20 in total

Review 1.  The Use of Medicinal Plants for the Treatment of Alopecia in the Canon of Avicenna: An Evidence-Based Review.

Authors:  Zahra Boghrati; Sara Sabouri-Rad; Seyed Ahmad Emami; Mohsen Tahaghoghi Saber; Amirhossein Sahebkar; Zahra Tayarani-Najaran
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Androgenetic alopecia: a review.

Authors:  Francesca Lolli; Francesco Pallotti; Alfredo Rossi; Maria C Fortuna; Gemma Caro; Andrea Lenzi; Andrea Sansone; Francesco Lombardo
Journal:  Endocrine       Date:  2017-03-28       Impact factor: 3.633

Review 3.  Hormonal Contraceptives and Dermatology.

Authors:  Natalie M Williams; Michael Randolph; Ali Rajabi-Estarabadi; Jonette Keri; Antonella Tosti
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

Review 4.  Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.

Authors:  Raquel N Rozner; Azael Freites-Martinez; Jerry Shapiro; Eliza B Geer; Shari Goldfarb; Mario E Lacouture
Journal:  Breast Cancer Res Treat       Date:  2018-11-22       Impact factor: 4.872

Review 5.  Female Pattern Hair Loss: a clinical and pathophysiological review.

Authors:  Paulo Müller Ramos; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.896

Review 6.  Female pattern hair loss.

Authors:  Ingrid Herskovitz; Antonella Tosti
Journal:  Int J Endocrinol Metab       Date:  2013-10-21

Review 7.  The female pattern hair loss: review of etiopathogenesis and diagnosis.

Authors:  Anja Vujovic; Véronique Del Marmol
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

8.  [Drug treatment of alopecia].

Authors:  H Wolff
Journal:  Internist (Berl)       Date:  2015-10       Impact factor: 0.743

Review 9.  Female pattern alopecia: current perspectives.

Authors:  Lauren L Levy; Jason J Emer
Journal:  Int J Womens Health       Date:  2013-08-29

Review 10.  Estrogens and aging skin.

Authors:  M Julie Thornton
Journal:  Dermatoendocrinol       Date:  2013-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.